Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of the 2023 Gilead ALL4LIVER Grant, a grant program with the theme of ‘Test. Link. Prioritize’, designed to support innovative projects that drive testing, improve linkage to care and/or elevate viral hepatitis on the public health agenda. The .
GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030 vietnamtribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietnamtribune.com Daily Mail and Mail on Sunday newspapers.